TCL Archive New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science January 8, 1999
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012